FAP and Myocardial fibrosis: Studies from the University of Pennsylvania in 2019 [10] and 2022 [11] demonstrated that CAR-T cells can effectively target and eliminate FAP-expressing myoFbs, thereby inhibiting myocardial fibrosis.